SavedAdd your journal

Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 12

Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis

Pervin KARLI
Bahattin AVCI
Hatice KAYABAŞ
Fatma DEVRAN BILDIRCIN
Ayşe Zehra ÖZDEMİR
Tayfun ALPER
Pages
2802–2806
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Levels of SAA were determined in maternal venous and umbilical cord blood.Results: SAA values in cord blood and venous blood of mothers with PPROM were higher than in the control group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To determine the efficiency of serum amyloid-A (SAA) in predicting preterm premature rupture of membrane (PPROM) andchorioamnionitis in risky cases.Study Design: The study consists of 20 women 26-37 weeks of pregnancy who had PPROM and 20 pregnant women without waterbreaks.
📊
Key Findings & Data:Aim: To determine the efficiency of serum amyloid-A (SAA) in predicting preterm premature rupture of membrane (PPROM) andchorioamnionitis in risky cases.Study Design: The study consists of 20 women 26-37 weeks of pregnancy who had PPROM and 20 pregnant women without waterbreaks.
💡
Conclusion & Impact:Levels of SAA were determined in maternal venous and umbilical cord blood.Results: SAA values in cord blood and venous blood of mothers with PPROM were higher than in the control group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To determine the efficiency of serum amyloid-A (SAA) in predicting preterm premature rupture of membrane (PPROM) andchorioamnionitis in risky cases.Study Design: The study consists of 20 women 26-37 weeks of pregnancy who had PPROM and 20 pregnant women without waterbreaks. Levels of SAA were determined in maternal venous and umbilical cord blood.Results: SAA values in cord blood and venous blood of mothers with PPROM were higher than in the control group (p

🔖

Cite This Article

KARLI, P., AVCI, B., KAYABAŞ, H., BILDIRCIN, F. D., ÖZDEMİR, A. Z., ALPER, T. (2022). Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis. Annals of Medical Research, Cilt: 26 - Sayı: 12, 2802–2806. https://ajindex.com/articles/446784

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Gabbe SG NJ, Simphson JL. Obstetrics;Normal and problem pregnancies. Third ed1996
  2. Alexander JM, Cox SM. Clinical course of premature rupture of the membranes. Semin Perinatol 1996;20:369-74
  3. Scott JR DJ, KHammond CB, Spellacy WN. Danforth’s Obstetrics Gynecol. Seventy edition 1994
  4. Duff P. Premature rupture of the membranes in term patients. Semin Perinatol 1996;20:401-8
  5. Ohlsson A. Treatments of preterm premature rupture of the membranes: a meta-analysis. Am J Obstet Gynecol 1989;160:890-906
  6. ACOG Committee on Practice Bulletins-Obstetrics a. Clinical management guidelines for obstetriciangynecologists. Obstetric Gynecology2007. p. 1007- 19
  7. Mercer BM, Goldenberg RL, Meis PJ, et al. The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000;183:738- 45
  8. Joseph KS, Kramer MS, Marcoux S, et al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med 1998;339:1434-9
  9. Bengtson JM, VanMarter LJ, Barss VA, et al. Pregnancy outcome after premature rupture of the membranes at or before 26 weeks’ gestation. Obstet Gynecol 1989;73:921-7
  10. Dale PO, Tanbo T, Bendvold E, Moe N. Duration of the latency period in preterm premature rupture of the membranes. Maternal and neonatal consequences of expectant management. Eur J Obstet Gynecol Reprod Biol 1989;30:257-62
  11. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178-93
  12. Mercer BM. Management of preterm premature rupture of the membranes. Clin Obstet Gynecol 1998;41:870-82
  13. Mercer BM. Antibiotic treatment for preterm premature rupture of membranes. Am J Obstet Gynecol 1996;175:755-6
  14. Parry S, Strauss JF, 3rd. Premature rupture of the fetal membranes. N Engl J Med 1998;338:663-70
  15. Harger JH, Hsing AW, Tuomala RE, et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990;163:130-7
  16. Asrat T, Garite TJ. Management of preterm premature rupture of membranes. Clin Obstet Gynecol 1991;34:730-41
  17. St Geme JW Jr, Murray DL, Carter J, et al. Perinatal bacterial infection after prolonged rupture of amniotic membranes: an analysis of risk and management. J Pediatr 1984;104:608-13
  18. Malle E, De Beer FC. Human serum amyloid A (SAA